Bio-Techne Newsroom

Citi Downgrades Bio-Techne to Neutral, Cites Valuation

Seeking AlphaMay 23 02:34

Citi: Bio-Techne (TECH.US) rating downgraded from buying to neutral, with a target price of $85.00.

Zhitong FinanceMay 22 20:41

Bio-Techne Analyst Ratings

BenzingaMay 22 20:40

Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target

MT NewswiresMay 22 17:54

Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating

MT NewswiresMay 6 17:58

Analysts' Top Healthcare Picks: Bio-Techne (TECH), Gilead Sciences (GILD)

TipRanksMay 2 21:45

RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept

MT NewswiresMay 2 20:18

Bio-Techne Analyst Ratings

BenzingaMay 2 18:55

Baird Maintains Outperform on Bio-Techne, Raises Price Target to $81

BenzingaMay 2 18:55

KeyBanc Remains a Buy on Bio-Techne (TECH)

TipRanksMay 2 16:10

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)

TipRanksMay 2 16:05

Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82

MT NewswiresMay 1 23:12

RBC Capital Sticks to Its Hold Rating for Bio-Techne (TECH)

TipRanksMay 1 09:50

RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79

MT NewswiresApr 29 21:42

Navigating 4 Analyst Ratings For Bio-Techne

BenzingaApr 19 00:08

Deutsche Bank: Maintaining the Bio-Techne (TECH.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $85.00 to $82.00.

Zhitong FinanceApr 18 20:21

Bio-Techne Analyst Ratings

BenzingaApr 18 20:15

RBC Capital Reaffirms Their Hold Rating on Bio-Techne (TECH)

TipRanksApr 9 09:51

RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating

MT NewswiresApr 8 19:47

Bio-Techne: Solid Consumables Business and Strategic Investments Anchor Buy Rating Amid Sector Headwinds

TipRanksFeb 5 17:05